Turner Bruce

Turner Bruce is listed in filings as Chief Strategy Officer at Immunome, Inc.. This profile follows SEC Form 4 activity through Aug 13, 2024, including 1 public disclosure. Recent filings connect the profile to Immunome, Inc. (IMNM). The current snapshot covers public activity from Aug 13, 2024. Reported amounts are shown as $1.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.